Journal article

Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation

John Nixon, Paul Newbold, Tomas Mustelin, Gary P Anderson, Roland Kolbeck

Pharmacology & Therapeutics | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2017

DOI: 10.1016/j.pharmthera.2016.10.016

Download PDF

University of Melbourne Researchers

Related Projects (1)

Project icon

Anticalins: Inhalable Biologicals For Severe Asthma

This grant aims to develop a new class of medicines called 'anticalins'. Anticalins behave like a successful class of medicines called monoc..

Grants

Funding Acknowledgements

Editing assistance was provided by Elizabeth Strickland, PhD, of JK Associates, Conshohocken, PA, and Michael A. Nissen, ELS, of AstraZeneca, Gaithersburg, MD. This assistance was funded by AstraZeneca, Gaithersburg, MD, USA.

Citation metrics

25Web of Science
31Scopus

Keywords

Antibodies, Monoclonal
Asthma
Respiratory Function Tests
Cytokines
Life Sciences & Biomedicine
Humans
Eosinophils
Interleukins
Prednisone-Dependent Asthma
Innate Lymphoid-Cells
Recombinant Human Interleukin-5
Bone-Mineral Density
Chronic Obstructive Pulmonary Disease
Nitric-Oxide Levels
Neonatal Fc-Receptor
Anti-Asthmatic Agents
Receptors, Interleukin-5
Science & Technology
Interleukin-5
Pharmacology & Pharmacy
Biologic Therapy
Animals
Inflammation
Airway Inflammation
Messenger-Rna Expression
Colony-Stimulating Factor
Sputum Eosinophils
Pulmonary Disease, Chronic Obstructive